Cargando…
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
BACKGROUND: The ever-present threat of infectious disease, e.g. influenza pandemics, and the increasing need for new and effective treatments in immunotherapy are the driving forces that motivate research into new and innovative vaccine platforms. Ideally, such platforms should trigger an efficient...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621093/ https://www.ncbi.nlm.nih.gov/pubmed/23556511 http://dx.doi.org/10.1186/1477-3155-11-10 |